A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: currentn         progress and challenges in evaluating molecularly targeted agents in ACC

L. L. Siu

首页> 外文期刊>Annals of Oncology >A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: currentn progress and challenges in evaluating molecularly targeted agents in ACC

【24h】

A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: currentn progress and challenges in evaluating molecularly targeted agents in ACC

机译：舒尼替尼在唾液腺复发和/或转移性腺样囊性癌（ACC）中的II期研究：目前的进展和评估ACC中分子靶向药物的挑战

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of Oncology》 |2012年第6期|p.1562-1570|共9页
作者
L. L. Siu;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: Current progress and challenges in evaluating molecularly targeted agents in ACC [J] . ChauN.G., HotteS.J., ChenE.X., Annals of oncology: official journal of the European Society for Medical Oncology . 2012,第6期

机译：舒尼替尼在唾液腺复发和/或转移性腺样囊性癌（ACC）中的II期研究：评估ACC中分子靶向药物的当前进展和挑战
2. Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands. [J] . Agulnik M, Cohen EW, Cohen RB, Journal of Clinical Oncology . 2007,第25期

机译：拉帕替尼在唾液腺表达腺样囊性癌和非腺样囊性癌的复发性或转移性表皮生长因子受体和/或erbB2的II期研究中。
3. Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors [J] . Wong S. J., Karrison T., Hayes D. N., Annals of oncology: official journal of the European Society for Medical Oncology . 2016,第2期

机译：达沙替尼用于复发或转移性表达c-KIT的腺样囊性癌和非腺样囊性恶性涎腺肿瘤的II期试验
4. Clinical and Radiological Study of Adenoid Cystic Carcinoma in Salivary gland, Sinonasal Tract and Nasopharyngeal [C] . Bo-Hong SHI, Yong-Mei HUANG, Tao QIN International Conference on Biological Sciences and Technology . 2016

机译：唾液腺腺体囊性癌，SinoNasal道和鼻咽癌的临床和放射学研究
5. Effects of small interfering RNA targeting thymidylate synthase on survival of ACC3 cells from salivary adenoid cystic carcinoma [O] . Takashi Shirasaki, Shin-ichiro Maruya, Hiroki Mizukami, 2008

机译：靶向胸苷酸合酶的小干扰RNA对涎腺腺样囊性癌ACC3细胞存活的影响
6. EP1.14-24 Lenvatinib for Recurrent Metastatic Adenoid Cystic Carcinomas (ACC) of the Lung [O] . L. Al Rabadi, K. Tolba 2019

机译：EP1.14-24 Lenvatinib用于肺的复发转移性腺样囊性癌（ACC）

A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: currentn progress and challenges in evaluating molecularly targeted agents in ACC

著录项

相似文献

相关主题

期刊订阅